S 3677

The Dietary Supplement Listing Act of 2026 aims to increase transparency in the dietary supplement industry by requiring manufacturers to register their products with the Food and Drug Administration (FDA). This registration would involve providing detailed information about the supplement’s ingredients, manufacturer, and labeling. The FDA would then maintain an online database accessible to the public, promoting better consumer awareness and oversight of these products. The bill also addresses potential violations by requiring notification of non-compliance and prohibiting the introduction of non-listed supplements.